[HTML][HTML] Important surgical and clinical end points in neoadjuvant immunotherapy trials in resectable NSCLC

JM Lee, AW Kim, T Marjanski, PE Falcoz… - JTO clinical and …, 2021 - Elsevier
Neoadjuvant immunotherapy may improve outcomes in patients with resectable NSCLC and
is being evaluated in phase 2 and 3 studies. Nevertheless, preoperative treatment …

Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway

YL Hsu, CY Wu, JY Hung, YS Lin, MS Huang… - …, 2013 - academic.oup.com
Lung cancer is a major cancer, leading in both incidence and mortality in the world, and
metastasis underlies the majority of lung cancer–related deaths. Galectin-1, a glycan …

Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf–Hirschhorn syndrome candidate 1/Twist pathway

CH Kuo, KF Chen, SH Chou, YF Huang, CY Wu… - …, 2013 - academic.oup.com
The interaction between tumors and their microenvironments leads to a vicious cycle, which
strengthens both immune suppression and cancer progression. The present study …

Heparan sulfate D-glucosamine 3-O-sulfotransferase 3B1 is a novel regulator of transforming growth factor-beta-mediated epithelial-to-mesenchymal transition and …

Z Zhang, H Jiang, Y Wang, M Shi - Journal of cancer research and …, 2018 - journals.lww.com
Background: Due to high metastasis and recurrence rate. Recent studies indicated that
epithelial-to-mesenchymal transition (EMT) was involved in the progression and metastasis …

Factors affecting accuracy of clinical staging in resectable non‐small cell lung cancer in a real‐world study

HR Gwon, A La Woo, SH Yong, Y Park, SY Kim… - Thoracic …, 2024 - Wiley Online Library
Background The clinical staging of non‐small cell lung cancer (NSCLC) is well known to be
related to their prognosis. However, there is usually a discrepancy between clinical staging …

[HTML][HTML] Prognostic factors in non-small cell lung cancer patients who received neoadjuvant therapy and curative resection

CP Hsieh, MJ Hsieh, CF Wu, JY Fu, YH Liu… - Journal of Thoracic …, 2016 - ncbi.nlm.nih.gov
Background Lung cancer is the leading cause of cancer deaths in the world, and more and
more treatment modalities have been introduced in order to improve patients' survival. For …

Inaccurate Clinical Stage is Common and Associated With Poor Survival in Patients With Lung Cancer

LM Poston, A Bassiri, J Kloos, J Linden, B Jiang… - Journal of Surgical …, 2024 - Elsevier
Introduction Clinical staging in lung cancer has implications for treatment planning and
prognosis. We sought to determine the rate of inaccurate clinical stage (relative to …

[PDF][PDF] Quality of life levels and physical and mental states of dyspnoeic patients with advanced lung cancer effectively improved by comprehensive nursing …

X Su, F Li, Q Zhao, T Zhao, M Yang, M Xu, J Li - Int J Clin Exp Med, 2019 - e-century.us
Objective: The aim of the current study was to investigate the effects of comprehensive
nursing intervention on quality of life levels, as well as physical and mental statuses, of …

What is the accuracy rate of preoperative T and N staging in rectal cancer?

D Gidey - 2021 - diva-portal.org
Aim: Is to evaluate the accuracy of preoperative staging in rectal cancer, and to estimate
theoccurrence of over-and understaging in order to observe patterns, intending to …

[PDF][PDF] Комбинированное лечение немелкоклеточного рака легкого II-III стадий с персонификацией адъювантной химиотерапии

ЕО Родионов, ММ Цыганов, ИВ Дерюшева - 2015 - vital.lib.tsu.ru
Материал и методы. Проанализированы результаты лечения 47 больных
немелкоклеточным раком легкого, находившихся в торакоабдоминальном отделении …